CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award Chief Executive Officer acquired 400,000 shares (grant or award)
- 4 Grant or award VP, Controller&Acct Principal acquired 75,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 125,000 shares (grant or award)
- 4 Grant or award Executive President acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 175,000 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Medical Officer sold 3,577 shares at $3.51 ($12,555)
- 4 Open-market sale Chief Executive Officer sold 8,273 shares at $3.51 ($29,038)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 3,861 shares at $2.69 ($10,386)
- 4 Open-market sale Chief Medical Officer sold 1,211 shares at $2.69 ($3,258)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Medical Officer sold 1,185 shares at an average $2.91 ($3,452)
Page 18 of 26 · 506 filings